{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:02:34Z","timestamp":1789614154058,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.breast.2026.104859","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:12:50Z","timestamp":1783494770000},"page":"104859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Availability and public reimbursement of early breast cancer care across European expert centres: a PORTRAIT from an EUSOMA initiative"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-0906","authenticated-orcid":false,"given":"Eduard-Alexandru","family":"Bonci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2575-8729","authenticated-orcid":false,"given":"Rosa","family":"Di Micco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Marotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5772-7740","authenticated-orcid":false,"given":"Marisa","family":"Miraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0035-0679","authenticated-orcid":false,"given":"Isabel T.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1781-2518","authenticated-orcid":false,"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8137-3700","authenticated-orcid":false,"given":"Maria-Joao","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2026.104859_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","author":"Kim","year":"2025","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.breast.2026.104859_bib2","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2026.104859_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejca.2021.04.026","article-title":"European trends in breast cancer mortality, 1980-2017 and predictions to 2025","volume":"152","author":"Wojtyla","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2026.104859_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.breast.2017.06.003","article-title":"Trends and predictions to 2020 in breast cancer mortality in Europe","volume":"36","author":"Carioli","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.breast.2026.104859_bib5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"Dyba","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2026.104859_bib7","series-title":"Beating cancer inequalities in the EU: spotlight on cancer prevention and early detection","year":"2024"},{"key":"10.1016\/j.breast.2026.104859_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2020.01.011","article-title":"The cost of cancer in Europe 2018","volume":"129","author":"Hofmarcher","year":"2020","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.breast.2026.104859_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1200\/JCO.19.01451","article-title":"Association between spending and outcomes for patients with cancer","volume":"38","author":"Li","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104859_bib10","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/S2214-109X(19)30463-2","article-title":"A comprehensive assessment of universal health coverage in 111 countries: a retrospective observational study","volume":"8","author":"Wagstaff","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"10439","key":"10.1016\/j.breast.2026.104859_bib11","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(24)00747-5","article-title":"The lancet breast cancer commission","volume":"403","author":"Coles","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.breast.2026.104859_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40258-016-0300-z","article-title":"How can pricing and reimbursement policies improve affordable access to medicines? Lessons learned from European countries","volume":"15","author":"Vogler","year":"2017","journal-title":"Appl Health Econ Health Policy"},{"issue":"3","key":"10.1016\/j.breast.2026.104859_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.annonc.2024.12.005","article-title":"ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update","volume":"36","author":"Cherny","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2026.104859_bib15","author":"Post"},{"issue":"1","key":"10.1016\/j.breast.2026.104859_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jclinepi.2013.08.005","article-title":"Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health","volume":"67","author":"O'Neill","year":"2014","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.breast.2026.104859_bib17","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2190\/986L-LHQ6-2VTE-YRRN","article-title":"The concepts and principles of equity and health","volume":"22","author":"Whitehead","year":"1992","journal-title":"Int J Health Serv"},{"key":"10.1016\/j.breast.2026.104859_bib18","series-title":"Health systems financing : the path to universal coverage","first-page":"106","author":"Evans","year":"2010"},{"key":"10.1016\/j.breast.2026.104859_bib20","unstructured":"Commission E. ECIR - European cancer inequalities. Accessed March 6, 2025. https:\/\/cancer-inequalities.jrc.ec.europa.eu\/."},{"key":"10.1016\/j.breast.2026.104859_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.breast.2020.12.010","article-title":"Why is appropriate healthcare inaccessible for many European breast cancer patients? - the EBCC 12 manifesto","volume":"55","author":"Cardoso","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.breast.2026.104859_bib26","author":"Organisation"},{"key":"10.1016\/j.breast.2026.104859_bib27","unstructured":"(EUSOMA) ESoBCS. Breast centres network. Accessed March 6, 2025. https:\/\/www.eusoma.org\/en\/data%2dcentre\/breast%2dcentres%2dnetwork\/1-452-1-."},{"issue":"11","key":"10.1016\/j.breast.2026.104859_bib28","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1007\/s00330-016-4267-9","article-title":"MR-guided vacuum-assisted breast biopsy of MRI-only lesions: a single center experience","volume":"26","author":"Spick","year":"2016","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.breast.2026.104859_bib29","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13244-019-0803-x","article-title":"Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging","volume":"11","author":"Bick","year":"2020","journal-title":"Insights Imaging"},{"key":"10.1016\/j.breast.2026.104859_bib30","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1186\/s12885-015-1664-4","article-title":"Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis","volume":"15","author":"Marinovich","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.breast.2026.104859_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41523-022-00475-1","article-title":"MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis","volume":"8","author":"Janssen","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"10","key":"10.1016\/j.breast.2026.104859_bib32","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1684\/bdc.2012.1652","article-title":"[Cost-effectiveness of a chemotherapy predictive test]","volume":"99","author":"Vataire","year":"2012","journal-title":"Bull Cancer"},{"issue":"6","key":"10.1016\/j.breast.2026.104859_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128880","article-title":"Economic impact of gene expression profiling in patients with early-stage breast cancer in France","volume":"10","author":"Katz","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.breast.2026.104859_bib34","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejso.2016.12.010","article-title":"Impact of oncotype DX breast recurrence score testing on adjuvant chemotherapy use in early breast cancer: real world experience in Greater Manchester, UK","volume":"43","author":"Loncaster","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.breast.2026.104859_bib35","article-title":"The impact of oncotype DX testing on adjuvant chemotherapy decision making in 1-3 node positive breast cancer","volume":"5","author":"Malam","year":"2022","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.breast.2026.104859_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104436","article-title":"Awareness of genomic testing among patients with breast cancer in Europe","volume":"81","author":"Cardone","year":"2025","journal-title":"Breast"},{"issue":"13","key":"10.1016\/j.breast.2026.104859_bib37","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1200\/JCO.20.01204","article-title":"Adjuvant pertuzumab and trastuzumab in early HER2-Positive breast cancer in the APHINITY trial: 6 years' Follow-Up","volume":"39","author":"Piccart","year":"2021","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.breast.2026.104859_bib38","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.23.01994","volume":"42","author":"Rastogi","year":"2024","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.breast.2026.104859_bib39","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant olaparib for patients with","volume":"384","author":"Tutt","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.breast.2026.104859_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.breast.2026.104859_bib41","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/bjs.10161","article-title":"National trends and regional variation in immediate breast reconstruction rates","volume":"103","author":"Jeevan","year":"2016","journal-title":"Br J Surg"},{"issue":"4","key":"10.1016\/j.breast.2026.104859_bib42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2648.2001.01865.x","article-title":"Psychological aspects of breast reconstruction: a review of the literature","volume":"35","author":"Harcourt","year":"2001","journal-title":"J Adv Nurs"},{"issue":"2","key":"10.1016\/j.breast.2026.104859_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znaf032","article-title":"Patient-reported outcomes 3 and 18 months after mastectomy and immediate prepectoral implant-based breast reconstruction in the UK Pre-BRA prospective multicentre cohort study","volume":"112","author":"Harvey","year":"2025","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.breast.2026.104859_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae306","article-title":"Clinical and patient-reported outcomes in women offered oncoplastic breast-conserving surgery as an alternative to mastectomy: ANTHEM multicentre prospective cohort study","volume":"112","author":"Davies","year":"2024","journal-title":"Br J Surg"},{"key":"10.1016\/j.breast.2026.104859_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-079089","article-title":"Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis","volume":"386","author":"Lee","year":"2024","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.breast.2026.104859_bib46","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clon.2020.12.008","article-title":"The financial impact on reimbursement of moderately hypofractionated postoperative radiation therapy for breast cancer: an international consortium report","volume":"33","author":"Marta","year":"2021","journal-title":"Clin Oncol"},{"issue":"1","key":"10.1016\/j.breast.2026.104859_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12889-024-17719-3","article-title":"Increasing access to fertility preservation for women with breast cancer: protocol for a stepped-wedge cluster randomized trial in France","volume":"24","author":"Addamiano","year":"2024","journal-title":"BMC Public Health"},{"issue":"1","key":"10.1016\/j.breast.2026.104859_bib48","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1038\/s41598-023-30423-3","article-title":"Access to information and oncofertility consultation for young women with breast cancer: a population-based study","volume":"13","author":"Martinet-Kosinski","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.breast.2026.104859_bib49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/pon.4044","article-title":"Psychosocial oncology care resources in Europe: a study under the European Partnership for Action Against Cancer (EPAAC)","volume":"26","author":"Travado","year":"2017","journal-title":"Psychooncology"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626001694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977626001694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:28:28Z","timestamp":1789612108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977626001694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0960977626001694"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104859","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Availability and public reimbursement of early breast cancer care across European expert centres: a PORTRAIT from an EUSOMA initiative","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104859"}}